Ability Beyond toasted the monumental contributions of the individuals who lend their time and talents to improve the lives of people with disabilities at its annual appreciation event on December 13th.
The nonprofit organization honored more than 50 board and committee members at the cocktail reception held at Maplewood Senior Living headquarters in Westport, CT.
Ability Beyond provides job training and placement, supported living, and recreational and educational opportunities to more than 3,000 people in Connecticut.
For over 60 years, Ability Beyond has led the way in providing award-winning initiatives and programs to support optimum well-being and honor the dignity and pride of people with developmental, intellectual, autism spectrum and mental health disabilities across Connecticut with locations.
“It is only through the personal dedication and generous financial support of these amazing people that we are able to offer exceptional services and programs that have benefitted countless families,” said Jane Davis, President and CEO of Ability Beyond. “We are so grateful for their support. We would also like to thank Greg Smith, CEO of Maplewood Senior Living, for hosting this outstanding event.”
For more information about Ability Beyond go to www.abilitybeyond.org.
The Roundup currently has over 5,700 subscriptions and a local social media following of over 95,000 readers across multiple social media sites, apps, pages, and groups.
The Roundup is also a proud member of WordPress. This affiliation offers readers more news from FOX 61 and CBS Connecticut on The Roundup.
Recent Posts From Roundup Partner: CBS Connecticut
Two U.S. athletes have been placed on probation for 12 months for their political protests last week at the Pan Am Games.
CBS Sports HQ’s second annual live Fantasy Football Telethon will include expert advice from NFL experts, along with Q&As with former players.
A chemical found in the cannabis plant has demonstrated “significant therapy potential” in treatment of pancreatic cancer, according to researchers from Harvard University’s Dana-Farber Cancer Institute.